Literature DB >> 11264008

HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides.

E Papadimitriou1, A Polykratis, J Courty, P Koolwijk, M Heroult, P Katsoris.   

Abstract

HARP (heparin affin regulatory peptide) is a growth factor displaying high affinity for heparin. In the present work, we studied the ability of human recombinant HARP as well as its two terminal peptides (HARP residues 1-21 and residues 121-139) to promote angiogenesis. HARP stimulates endothelial cell tube formation on matrigel, collagen and fibrin gels, stimulates endothelial cell migration and induces angiogenesis in the in vivo chicken embryo chorioallantoic membrane assay. The two HARP peptides seem to be involved in most of the angiogenic effects of HARP. They both stimulate in vivo angiogenesis and in vitro endothelial cell migration and tube formation on matrigel. We conclude that HARP has an angiogenic activity when applied exogenously in several in vitro and in vivo models of angiogenesis and its NH(2) and COOH termini seem to play an important role. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264008     DOI: 10.1006/bbrc.2001.4574

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Exogenous pleiotrophin applied to lesioned nerve impairs muscle reinnervation.

Authors:  Brigitte Blondet; Gilles Carpentier; Arnaud Ferry; José Courty
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

Review 2.  Pleiotrophin: Activity and mechanism.

Authors:  Xu Wang
Journal:  Adv Clin Chem       Date:  2020-03-12       Impact factor: 5.394

3.  Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration.

Authors:  Marina Koutsioumpa; Christos Polytarchou; José Courty; Yue Zhang; Nelly Kieffer; Constantinos Mikelis; Spyros S Skandalis; Ulf Hellman; Dimitrios Iliopoulos; Evangelia Papadimitriou
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

4.  A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ.

Authors:  Zoi Diamantopoulou; Oya Bermek; Apostolos Polykratis; Yamina Hamma-Kourbali; Jean Delbé; José Courty; Panagiotis Katsoris
Journal:  Mol Cancer       Date:  2010-08-25       Impact factor: 27.401

5.  Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.

Authors:  Richard A Dean; Georgina S Butler; Yamina Hamma-Kourbali; Jean Delbé; David R Brigstock; José Courty; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

6.  An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.

Authors:  Geetika Sethi; Harsh B Pathak; Hong Zhang; Yan Zhou; Margret B Einarson; Vinod Vathipadiekal; Sumedha Gunewardena; Michael J Birrer; Andrew K Godwin
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

7.  Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin.

Authors:  Marina Koutsioumpa; Georgia Drosou; Constantinos Mikelis; Katerina Theochari; Dionussios Vourtsis; Panagiotis Katsoris; Efstathia Giannopoulou; Jose Courty; Christos Petrou; Vassiliki Magafa; Paul Cordopatis; Evangelia Papadimitriou
Journal:  Vasc Cell       Date:  2012-03-16

8.  Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication.

Authors:  Kemin Tan; Mark Duquette; Jin-huan Liu; Yicheng Dong; Rongguang Zhang; Andrzej Joachimiak; Jack Lawler; Jia-huai Wang
Journal:  J Cell Biol       Date:  2002-10-21       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.